[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340933-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340933-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","innate-and-adaptive-immune-directed-tumour-microenvironment-in-pancreatic-ductal-adenocarcinoma","Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma","","Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal, aggressive cancer often diagnosed at advanced stages, with poor survival driven by challenges in early detection, limited curative resection, weak responses to chemo- and radiotherapy, and immunotherapy resistance. The review highlights desmoplastic stromal barriers, phenotypic heterogeneity, drug resistance, and immunosuppressive tumour microenvironment shaped by cellular and humoral factors. It summarizes roles of innate and adaptive immune cells, immune-modulating humoral mechanisms, innate immune-mediated therapeutic advances, and recent clinical trials. Key focus includes immune surveillance versus immune suppression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/innate-and-adaptive-immune-directed-tumour-microenvironment-in-pancreatic-ductal-adenocarcinoma/340933/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/innate-and-adaptive-immune-directed-tumour-microenvironment-in-pancreatic-ductal-adenocarcinoma/340933.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is PDAC prognosis generally poor?","Question",{"text":63,"@type":64},"PDAC has poor outcomes due to difficulties in early identification, low probability of curative radical resection, limited responses to chemotherapy and radiotherapy, and immunotherapy resistance.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the tumour microenvironment contribute to PDAC aggressiveness?",{"text":68,"@type":64},"An extensive desmoplastic stroma forms a mechanical barrier that restricts vascularization and limits immune cell penetration. Phenotypic heterogeneity, drug resistance, and an immunosuppressive microenvironment further drive aggressiveness.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the review cover regarding immune-directed approaches in PDAC?",{"text":72,"@type":64},"The review describes roles of innate and adaptive immune cells, complex tumour microenvironment, humoral factors, innate immune-mediated therapeutic advances, and recent clinical trials in PDAC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340933,1790182191,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","TYPE Review  \nPUBLISHED 07 February 2024 DOI 10.3389/fimmu.2024.1323198  \nOPEN ACCESS  \nEDITED BY  \nJuana Serrano Lopez,  \nHealth Research Institute Foundation Jimenez Diaz (IIS-FJD), Spain  \nREVIEWED BY  \nJean-Rene´ Pallandre,  \nINSERM U1098 Interactions Hˆote-GreffonTumeur & Inge´nierie Cellulaire et Ge´nique,  \nFrance  \nSomchai Chutipongtanate, University of Cincinnati, United States  \n*CORRESPONDENCE Uday Kishore  \n [ukishore@hotmail.com](ukishore@hotmail.com);  \n [uday.kishore@uaeu.ac.ae](uday.kishore@uaeu.ac.ae)  \nRECEIVED 17 October 2023  \nACCEPTED 11 January 2024  \nPUBLISHED 07 February 2024  \nCITATION  \nJoseph AM, Al Aiyan A, Al-Ramadi B, Singh SK and Kishore U (2024) Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma.  \nFront. Immunol. 15:1323198 .  \ndoi: 10.3389/fimmu.2024.1323198  \nCOPYRIGHT  \n© 2024 Joseph, Al Aiyan, Al-Ramadi, Singh and Kishore. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nInnate and adaptive  \nimmune-directed tumour microenvironment in pancreatic ductal adenocarcinoma  \nAnn Mary Joseph1, Ahmad Al Aiyan 1, Basel Al-Ramadi 2,3,4, Shiv K. Singh 5 and Uday Kishore 1,3*  \n1 Department of Veterinary Medicine (CAVM), United Arab Emirates University, Al Ain, United Arab Emirates, 2 Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates, 3Zayed Center for Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates, 4ASPIRE Precision Medicine Research Institute Abu Dhabi, United Arab Emirates University, Al Ain, United Arab Emirates,  \n5 Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center, Goettingen, Germany  \nOne of the most deadly and aggressive cancers in the world, pancreatic ductaladenocarcinoma (PDAC), typically manifests at an advanced stage. PDAC is becoming more common, and by the year 2030, it is expected to overtake lung cancer as the second greatest cause of cancer-related death. The poor prognosis can be attributed to a number of factors, including difﬁculties in early identiﬁcation, a poor probability of curative radical resection, limited response to chemotherapy and radiotherapy, and its immunotherapy resistance. Furthermore, an extensive desmoplastic stroma that surrounds PDAC forms a mechanical barrier that prevents vascularization and promotes poor immune cell penetration. Phenotypic heterogeneity, drug resistance, and immunosuppressive tumor microenvironment are the main causes of PDAC aggressiveness. There is a complex and dynamic interaction between tumor cells in PDAC with stromal cells within the tumour immune microenvironment. The immune suppressive microenvironment that promotes PDAC aggressiveness is contributed by a range of cellular and humoral factors, which itself are modulated by the cancer. In this review, we describe the role of innate and adaptive immune cells, complex tumor microenvironment in PDAC, humoral factors, innate immune-mediated therapeutic advances, and recent clinical trials in PDAC.  \nKEYWORDS  \nPDAC, TME, immune surveillance, immune suppression, EMT, macrophages, TNF-a  \nAbbreviations: PDAC, Pancreatic Ductal Adenocarcinoma; TME, Tumor microenvironment; ADM, acinarto-ductal metaplasia; IL, Interleukin; CAF, Cancer Associated Fibroblast; TAMs, Tumor associated Macrophages; TANs, Tumor associated Neutrophils; ECM, Extracellular Matrix; Tregs, Regulatory T cells; Bregs, Regulatory B cells; MDSCs, Myeloid derived suppressor cells; TP53, Tumor Protein P53; CDKN2A, C","cbCaitvmmGSY8u3Z","https://ap.wps.com/l/cbCaitvmmGSY8u3Z","pdf",3489555,21,"English","# Introduction\n## Immunosuppressive tumour microenvironment in PDAC\n# Innate and adaptive immune cells in PDAC\n## Humoral factors shaping the immune microenvironment\n# Innate immune-mediated therapeutic advances\n## Recent clinical trials in PDAC","[{\"question\":\"Why is PDAC prognosis generally poor?\",\"answer\":\"PDAC has poor outcomes due to difficulties in early identification, low probability of curative radical resection, limited responses to chemotherapy and radiotherapy, and immunotherapy resistance.\"},{\"question\":\"How does the tumour microenvironment contribute to PDAC aggressiveness?\",\"answer\":\"An extensive desmoplastic stroma forms a mechanical barrier that restricts vascularization and limits immune cell penetration. Phenotypic heterogeneity, drug resistance, and an immunosuppressive microenvironment further drive aggressiveness.\"},{\"question\":\"What does the review cover regarding immune-directed approaches in PDAC?\",\"answer\":\"The review describes roles of innate and adaptive immune cells, complex tumour microenvironment, humoral factors, innate immune-mediated therapeutic advances, and recent clinical trials in PDAC.\"}]","Innate and adaptive immune-directed tumour microenvironment in pancreatic ductal adenocarcinoma | PDF",1790039595,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e38228d9bbb2839863cbfd0d0ec09e9b.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/614100f69dad82f8d7b8f08dfeb9b4de.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/986c036fc80f656b7e39bc9e74763533.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1ed940d4272276c8bf068a3b57e2f50.webp",980,1385]